| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.2 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |